Overcoming Obstacles in the Radiopharmaceutical Supply Chain from Phase 1 to Commercial Supply

Time: 7:30 pm
day: Day One


  •  What special considerations exist for phase I trials in TRT
  • How do you scale these operations through clinical development and how do those considerations change?
  • How does the theranostic pairing of (Cu-64/Cu-67) unique address these constraints and providing larger market access opportunities